vs
BED BATH & BEYOND, INC.(BBBY)与REPLIGEN CORP(RGEN)财务数据对比。点击上方公司名可切换其他公司
BED BATH & BEYOND, INC.的季度营收约是REPLIGEN CORP的1.3倍($247.8M vs $197.9M),REPLIGEN CORP净利率更高(6.7% vs -6.6%,领先13.3%),REPLIGEN CORP同比增速更快(13.6% vs 6.9%),REPLIGEN CORP自由现金流更多($17.6M vs $-12.8M),过去两年REPLIGEN CORP的营收复合增速更高(14.4% vs -21.1%)
Bed Bath & Beyond曾是美国大型零售连锁企业,主营家居用品、家具及特色家居商品,总部位于新泽西州尤宁郡,业务覆盖美国与加拿大,曾经一度跻身财富世界500强与福布斯全球2000强榜单。该企业于2023年4月申请破产清算,关闭所有剩余门店,现已转型为线上零售品牌。
Repligen是一家全球生命科学企业,专注于创新生物工艺技术与系统的研发及商业化,助力提升生物药生产效率。公司1981年成立,总部位于美国马萨诸塞州沃尔瑟姆,于纳斯达克挂牌上市,股票代码RGEN,截至2025年全球员工超1900人,主要服务生物制药领域客户。
BBBY vs RGEN — 直观对比
营收规模更大
BBBY
是对方的1.3倍
$197.9M
营收增速更快
RGEN
高出6.7%
6.9%
净利率更高
RGEN
高出13.3%
-6.6%
自由现金流更多
RGEN
多$30.4M
$-12.8M
两年增速更快
RGEN
近两年复合增速
-21.1%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $247.8M | $197.9M |
| 净利润 | $-16.4M | $13.3M |
| 毛利率 | 23.9% | 52.5% |
| 营业利润率 | 68.8% | 9.0% |
| 净利率 | -6.6% | 6.7% |
| 营收同比 | 6.9% | 13.6% |
| 净利润同比 | 58.9% | 143.9% |
| 每股收益(稀释后) | $-0.24 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
BBBY
RGEN
| Q1 26 | $247.8M | — | ||
| Q4 25 | $273.4M | $197.9M | ||
| Q3 25 | $257.2M | $188.8M | ||
| Q2 25 | $282.3M | $182.4M | ||
| Q1 25 | $231.7M | $169.2M | ||
| Q4 24 | $303.2M | $174.1M | ||
| Q3 24 | $311.4M | $154.9M | ||
| Q2 24 | $398.1M | $154.1M |
净利润
BBBY
RGEN
| Q1 26 | $-16.4M | — | ||
| Q4 25 | $-20.9M | $13.3M | ||
| Q3 25 | $-4.5M | $14.9M | ||
| Q2 25 | $-19.3M | $14.9M | ||
| Q1 25 | $-39.9M | $5.8M | ||
| Q4 24 | $-81.3M | $-30.3M | ||
| Q3 24 | $-61.0M | $-654.0K | ||
| Q2 24 | $-42.6M | $3.3M |
毛利率
BBBY
RGEN
| Q1 26 | 23.9% | — | ||
| Q4 25 | 24.6% | 52.5% | ||
| Q3 25 | 25.3% | 53.2% | ||
| Q2 25 | 23.7% | 50.0% | ||
| Q1 25 | 25.1% | 53.6% | ||
| Q4 24 | 23.0% | 26.1% | ||
| Q3 24 | 21.2% | 50.0% | ||
| Q2 24 | 20.1% | 49.8% |
营业利润率
BBBY
RGEN
| Q1 26 | 68.8% | — | ||
| Q4 25 | -4.8% | 9.0% | ||
| Q3 25 | -4.8% | 8.9% | ||
| Q2 25 | -4.4% | 7.6% | ||
| Q1 25 | -10.0% | 3.9% | ||
| Q4 24 | -11.3% | -17.7% | ||
| Q3 24 | -14.5% | -5.1% | ||
| Q2 24 | -11.8% | 1.0% |
净利率
BBBY
RGEN
| Q1 26 | -6.6% | — | ||
| Q4 25 | -7.6% | 6.7% | ||
| Q3 25 | -1.8% | 7.9% | ||
| Q2 25 | -6.8% | 8.2% | ||
| Q1 25 | -17.2% | 3.4% | ||
| Q4 24 | -26.8% | -17.4% | ||
| Q3 24 | -19.6% | -0.4% | ||
| Q2 24 | -10.7% | 2.2% |
每股收益(稀释后)
BBBY
RGEN
| Q1 26 | $-0.24 | — | ||
| Q4 25 | $-0.26 | $0.24 | ||
| Q3 25 | $-0.07 | $0.26 | ||
| Q2 25 | $-0.34 | $0.26 | ||
| Q1 25 | $-0.74 | $0.10 | ||
| Q4 24 | $-1.68 | $-0.55 | ||
| Q3 24 | $-1.33 | $-0.01 | ||
| Q2 24 | $-0.93 | $0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $135.8M | $767.6M |
| 总债务越低越好 | — | $542.2M |
| 股东权益账面价值 | $202.5M | $2.1B |
| 总资产 | $404.5M | $2.9B |
| 负债/权益比越低杠杆越低 | — | 0.26× |
8季度趋势,按日历期对齐
现金及短期投资
BBBY
RGEN
| Q1 26 | $135.8M | — | ||
| Q4 25 | $175.3M | $767.6M | ||
| Q3 25 | $167.4M | $748.7M | ||
| Q2 25 | $120.6M | $708.9M | ||
| Q1 25 | $114.6M | $697.2M | ||
| Q4 24 | $159.2M | $757.4M | ||
| Q3 24 | $140.4M | $784.0M | ||
| Q2 24 | $186.2M | $809.1M |
总债务
BBBY
RGEN
| Q1 26 | — | — | ||
| Q4 25 | — | $542.2M | ||
| Q3 25 | — | $537.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $525.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益
BBBY
RGEN
| Q1 26 | $202.5M | — | ||
| Q4 25 | $217.6M | $2.1B | ||
| Q3 25 | $202.6M | $2.1B | ||
| Q2 25 | $130.9M | $2.1B | ||
| Q1 25 | $143.4M | $2.0B | ||
| Q4 24 | $162.7M | $2.0B | ||
| Q3 24 | $196.2M | $2.0B | ||
| Q2 24 | $250.4M | $2.0B |
总资产
BBBY
RGEN
| Q1 26 | $404.5M | — | ||
| Q4 25 | $425.5M | $2.9B | ||
| Q3 25 | $414.4M | $2.9B | ||
| Q2 25 | $358.1M | $2.9B | ||
| Q1 25 | $363.7M | $2.9B | ||
| Q4 24 | $402.0M | $2.8B | ||
| Q3 24 | $428.3M | $2.8B | ||
| Q2 24 | $496.8M | $2.9B |
负债/权益比
BBBY
RGEN
| Q1 26 | — | — | ||
| Q4 25 | — | 0.26× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-11.8M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $-12.8M | $17.6M |
| 自由现金流率自由现金流/营收 | -5.2% | 8.9% |
| 资本支出强度资本支出/营收 | — | 4.1% |
| 现金转化率经营现金流/净利润 | — | 1.93× |
| 过去12个月自由现金流最近4个季度 | $-24.8M | $93.9M |
8季度趋势,按日历期对齐
经营现金流
BBBY
RGEN
| Q1 26 | $-11.8M | — | ||
| Q4 25 | $-6.5M | $25.7M | ||
| Q3 25 | $-15.1M | $48.1M | ||
| Q2 25 | $15.8M | $28.6M | ||
| Q1 25 | $-50.9M | $15.0M | ||
| Q4 24 | $-21.7M | $39.2M | ||
| Q3 24 | $-42.1M | $49.3M | ||
| Q2 24 | $-75.9M | $42.2M |
自由现金流
BBBY
RGEN
| Q1 26 | $-12.8M | — | ||
| Q4 25 | $-8.6M | $17.6M | ||
| Q3 25 | $-17.4M | $43.4M | ||
| Q2 25 | $14.0M | $21.5M | ||
| Q1 25 | $-52.1M | $11.4M | ||
| Q4 24 | $-24.7M | $33.6M | ||
| Q3 24 | $-45.5M | $42.3M | ||
| Q2 24 | $-80.4M | $37.4M |
自由现金流率
BBBY
RGEN
| Q1 26 | -5.2% | — | ||
| Q4 25 | -3.2% | 8.9% | ||
| Q3 25 | -6.8% | 23.0% | ||
| Q2 25 | 5.0% | 11.8% | ||
| Q1 25 | -22.5% | 6.8% | ||
| Q4 24 | -8.1% | 19.3% | ||
| Q3 24 | -14.6% | 27.3% | ||
| Q2 24 | -20.2% | 24.3% |
资本支出强度
BBBY
RGEN
| Q1 26 | — | — | ||
| Q4 25 | 0.8% | 4.1% | ||
| Q3 25 | 0.9% | 2.5% | ||
| Q2 25 | 0.6% | 3.9% | ||
| Q1 25 | 0.5% | 2.1% | ||
| Q4 24 | 1.0% | 3.2% | ||
| Q3 24 | 1.1% | 4.5% | ||
| Q2 24 | 1.1% | 3.1% |
现金转化率
BBBY
RGEN
| Q1 26 | — | — | ||
| Q4 25 | — | 1.93× | ||
| Q3 25 | — | 3.23× | ||
| Q2 25 | — | 1.92× | ||
| Q1 25 | — | 2.57× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 12.70× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图